| 注册
首页|期刊导航|中国临床药理学杂志|非酒精性脂肪肝治疗新药研究进展

非酒精性脂肪肝治疗新药研究进展

王梦瑶 黄志军

中国临床药理学杂志2018,Vol.34Issue(20):2452-2455,4.
中国临床药理学杂志2018,Vol.34Issue(20):2452-2455,4.DOI:10.13699/j.cnki.1001-6821.2018.20.017

非酒精性脂肪肝治疗新药研究进展

Recent advance in novel drug development for non-alcoholic fatty liver disease

王梦瑶 1黄志军1

作者信息

  • 1. 中南大学 湘雅三医院 临床药理中心,长沙410013
  • 折叠

摘要

Abstract

Non -alcoholic fatty liver disease ( NAFLD) has become a major global public health issue and NAFLD incidence increases drama-tically in China.Novel drug development against NAFLD received in-creased attention, although none has been approved so far .This review summarized major therapeutic targets of NAFLD and their potential mo-lecular mechanisms , specifically emphasizing drugs currently in the clini-cal trials and natural medicine .Our work aims to provide references for developing safe and efficient drugs against NAFLD .

关键词

非酒精性脂肪肝/治疗靶点/新药/临床试验/天然药物

Key words

non -alcoholic fatty liver disease/therapeutic target/new drug/clinical trial/natural medicine

分类

医药卫生

引用本文复制引用

王梦瑶,黄志军..非酒精性脂肪肝治疗新药研究进展[J].中国临床药理学杂志,2018,34(20):2452-2455,4.

基金项目

国家自然科学基金资助项目(81673520) (81673520)

中国临床药理学杂志

OA北大核心CSCDCSTPCD

1001-6821

访问量0
|
下载量0
段落导航相关论文